-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, EXY1As5jrCj8vslmTmLg43m6DWuyTbx+Y49C04VDN5ouUuaTYlfoQV9qk7Y2O9La /VBU5OB8uG265Jq3CyEjKg== 0001317757-09-000018.txt : 20091112 0001317757-09-000018.hdr.sgml : 20091111 20091112162500 ACCESSION NUMBER: 0001317757-09-000018 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20091109 FILED AS OF DATE: 20091112 DATE AS OF CHANGE: 20091112 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pereira Brian JG CENTRAL INDEX KEY: 0001298146 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10865 FILM NUMBER: 091177388 MAIL ADDRESS: STREET 1: C/O ADVANCED MAGNETICS, INC. STREET 2: 61 MOONEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02138 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMAG PHARMACEUTICALS INC. CENTRAL INDEX KEY: 0000792977 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 042742593 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 HAYDEN AVENUE CITY: LEXINGTON STATE: MA ZIP: 02140 BUSINESS PHONE: 6174972070 MAIL ADDRESS: STREET 1: 100 HAYDEN AVENUE CITY: LEXINGTON STATE: MA ZIP: 02140 FORMER COMPANY: FORMER CONFORMED NAME: ADVANCED MAGNETICS INC DATE OF NAME CHANGE: 19920703 4 1 primary_doc.xml PRIMARY DOCUMENT X0303 4 2009-11-09 0 0000792977 AMAG PHARMACEUTICALS INC. AMAG 0001298146 Pereira Brian JG C/O AMAG PHARMACEUTICALS, INC. 100 HAYDEN AVENUE LEXINGTON MA 02421 1 1 0 0 President and CEO Common Stock 2009-11-09 4 M 0 55300 9.1 A 88267 D Common Stock 2009-11-09 4 S 0 55300 44.254 D 32967 D Common Stock 2009-11-09 4 M 0 50744 9.1 A 83711 D Common Stock 2009-11-09 4 S 0 50744 43.476 D 32967 D Common Stock 2009-11-09 4 S 0 32967 44.823 D 0 I By self as Trustee Common Stock 2009-11-09 4 M 0 8000 8.98 A 8000 D Common Stock 2009-11-09 4 S 0 8000 43.347 D 0 D Common Stock 2009-11-10 4 M 0 15000 13.45 A 15000 D Common Stock 2009-11-10 4 S 0 15000 43.39 D 0 D Common Stock 2009-11-10 4 M 0 8000 13.55 A 8000 D Common Stock 2009-11-10 4 S 0 8000 43.149 D 0 D Common Stock 2009-11-10 4 M 0 60000 10.8 A 60000 D Common Stock 2009-11-10 4 S 0 60000 43.195 D 0 D Employee Stock Options (Right to Buy) 9.1 2009-11-09 4 M 0 55300 0 D 2015-11-16 Common 55300 50744 D Employee Stock Options (Right to Buy) 9.1 2009-11-09 4 M 0 50744 0 D 2015-11-16 Common 50744 0 D Employee Stock Options (Right to Buy) 8.98 2009-11-09 4 M 0 8000 0 D 2015-11-01 Common 8000 0 D Employee Stock Options (Right to Buy) 13.45 2009-11-10 4 M 0 15000 0 D 2014-07-26 Common 15000 0 D Employee Stock Options (Right to Buy) 13.55 2009-11-10 4 M 0 8000 0 D 2014-11-02 Common 8000 0 D Employee Stock Option (Right to Buy) 10.8 2009-11-10 4 M 0 60000 0 D 2015-07-12 Common 60000 0 D The shares sold on this date were sold in multiple transactions. The price is the weighted average sales price per share of all shares sold in this transaction. The actual sales prices range from $44.625-$43.640. Upon request by the Securities and Exchange Commission, the issuer, or any security holder of the issuer, the reporting person will provide full information regarding the number of shares sold at each price. The shares sold on this date were sold in multiple transactions. The price is the weighted average sales price per share of all shares sold in this transaction. The actual sales prices range from $43.62-$43.10. Upon request by the Securities and Exchange Commission, the issuer, or any security holder of the issuer, the reporting person will provide full information regarding the number of shares sold at each price. The shares sold on this date were sold in multiple transactions. The price is the weighted average sales price per share of all shares sold in this transaction. The actual sales prices range from $44.60-$45.09. Upon request of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, the reporting person will provide full information regarding the number of shares sold at each price. 12,211 of these shares were held in The Brian J.G. Pereira 2004 Trust, and 20,756 of the shares were held in the Brian Pereira Grantor Retained Annuity Trust. Dr. Pereira is the Trustee of both trusts. The shares sold on this date were sold in multiple transactions. The price is the weighted average sales price per share of all shares sold in this transaction. The actual sales prices range from $43.57-$43.14. Upon request by the Securities and Exchange Commission, the issuer, or any security holder of the issuer, the reporting person will provide full information regarding the number of shares sold at each price. The shares sold on this date were sold in multiple transactions. The price is the weighted average sales price per share of all shares sold in this transaction. The actual sales prices range from $43.51-$43.17. Upon request by the Securities and Exchange Commission, the issuer, or any security holder of the issuer, the reporting person will provide full information regarding the number of shares sold at each price. The shares sold on this date were sold in multiple transactions. The price is the weighted average sales price per share of all shares sold in this transaction. The actual sales prices range from $43.24-$43.00. Upon request by the Securities and Exchange Commission, the issuer, or any security holder of the issuer, the reporting person will provide full information regarding the number of shares sold at each price. The shares sold on this date were sold in multiple transactions. The price is the weighted average sales price per share of all shares sold in this transaction. The actual sales prices range from $43.95-$43.00. Upon request by the Securities and Exchange Commission, the issuer, or any security holder of the issuer, the reporting person will provide full information regarding the number of shares sold at each price. Not applicable Joseph L. Farmer, attorney-in-fact 2009-11-12 -----END PRIVACY-ENHANCED MESSAGE-----